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Evidence for intimate interconnections between the three major systems of cell 
communication, the nervous, endocrine and immune systems, has opened important novel 
research perspectives. Neuroimmune-endocrine interactions are now established as crucial 
factors for the control of body development and homeostasis. In distant species and 
invertebrates, the foundations of both the neuroendocrine system and innate immunity were 
coexisting until now without any apparent problem. Some 300 millions years ago, in a 
relatively short period after agnathan fishes (e.g., hagfish and lamprey), adaptive immunity 
emerged in the first gnathostomes, cartilaginous fishes (e.g., shark and ray). Somatic 
recombination machinery characterizes adaptive immunity and is responsible for the random 
generation of the huge diversity of immune receptors able to recognize infectious antigens. 
The emergence of this novel form of immune defenses exerted a so potent pressure that 
structures and mechanisms developed along the paths of lymphocyte traffic to impose 
immunological self-tolerance, that is, the inability of the immune system to attack the host 
organism. Together with the generation of diversity and memory, self-tolerance constitutes a 
fundamental property of the immune system. The progressive rise in the level of immune 
diversity and complexity also explains why self-tolerance failures (i.e., organ-specific 
autoimmune diseases) were increasingly detected during evolution, the maximum being 
currently observed in the human species. The first thymus appeared in cartilaginous fishes 
(chondrichthyes), concomitantly with the emergence of rudimental forms of adaptive 
immunity. Though some forms of tolerance induction already takes place in primary 
hemopoietic sites (fetal liver and bone marrow), antigen-dependent B-cell tolerance is 
primarily due to an absence of T-cell help. Among all lymphoid structures, the thymus is the 
only organ specialized in the establishment of central self-tolerance. The thymus crucially 
stands at the crossroad between the immune and neuroendocrine systems. In this organ 
responsible for thymopoiesis—T-cell generation—(Kong et al., 1998), the neuroendocrine 
system regulates the process of T-cell differentiation from the very early stages. In addition, 
T lymphocytes undergo inside the thymus a complex educative process that establishes 
central T-cell self-tolerance of neuroendocrine principles (Geenen et al., 1992; Martens et al., 
1996). Within the thymus, a confrontation permanently occurs between previously 
established neuroendocrine principles and a recent system equipped with recombination 
machinery promoting stochastic generation of response diversity. Contrary to a previous 
assumption, the thymus functions throughout life (Poulin et al., 1999; Geenen et al., 2003) 
and plays a fundamental role in the recovery of a competent T-cell repertoire after intensive 
chemotherapy or during highly active antiretroviral therapy (Mackall et al., 1995; Douek et 
al., 1998). 
 
2. Development and cytoarchitecture of the thymus 
 
In the human species, the thymus is located in the anterior mediastinum, overlying the heart 
and the basal blood vessels. Its general shape resembles the leaves of the thyme plant. It is 
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divided into two lobes surrounded by a connective capsule. By sending incomplete septa, the 
capsule delineates thymic lobules further divided into distinct zones: subcapsular cortex, 
cortex, cortico-medullary junction, and medulla. The generation of a peripheral CD4+ and 
CD8+ T-cell pool occurs in the thymic organ that provides the appropriate cellular 
microenvironments. Thymocyte development is not a pure autonomous genetic program, but 
it closely depends on interactions of pre-T cells with the complex cellular network of the 
thymus. 
 
Thymic epithelial cells (TECs) constitute the major component of the thymus stroma and 
mainly derive from the endoderm of the third branchial pouch. In this endoderm, recent 
studies have identified epithelial stem cells able to form a thymus with normal phenotype and 
function in vivo (Bennett et al., 2002; Gill et al., 2002).  Further development of this primitive 
epithelial rudiment depends upon an important mesenchymal contribution from the cephalic 
neural crest (Bockman, 1997). Some human diseases (and animal models) include a defective 
thymus development leading to primary immune deficiencies. DiGeorge's syndrome 
associates congenital absence (or hypoplasia) of thymus, parathyroids, and defects in the 
heart and truncal vessels. This syndrome results from a migration failure of the cephalic 
neural crest. Mice in whom the homeobox gene Hoxa3 has been disrupted present thymic 
aplasia, parathyroid hypoplasia, and frequent defects in heart and great vessels. Wild animals 
with immune deficiencies most closely related to DiGeorge's syndrome are nude mice with 
hairlessness and lack of thymic development resulting from defect in epithelial cells. The 
nude phenotype is caused by mutations in nude gene on murine chromosome 11 encoding the 
transcription factor winged-helix nude (whn or Foxn1). In the absence of whn, the thymus 
anlage still develops but is filled with primitive epithelial cells that do not specialize and 
segregate into subregions. Other transcription factors (Pax-1, Pax-9) also contribute to the 
ontogeny of thymic epithelium.  
 
Thymic nurse cells (TNCs) are large epithelial cells located in the subcapsular and outer 
cortex. They contain the subcellular equipment and the enzymatic machinery required for 
antigen processing and presentation. Though they express various neuroendocrine markers 
and synthesize neuropeptides, their precise embryonic origin remains unknown. 
  
Thymic dendritic cells (DCs), mainly located at the cortico-medullary junction, and 
macrophages, without any precise topography, derive from bone marrow and constitute the 
other components of the thymic stroma.  
 
The thymus also receives sympathetic autonomic innervation (Bulloch, 1985). A number of 
neurotransmitters have been identified by immunocytochemistry within thymic sensory nerve 
fibers. 
 
The thymus is classically described as a lymphoepithelial structure. However, it is important 
to understand that the lymphoid compartment is a mobile population that originate as T-cell 
progenitors in primitive hemopoietic sites, migrate into the thymus, and differentiate through 
close contacts with the surrounding TECs/TNCs, DCs and macrophages. 
 
3. The dual role of the thymus in T-cell differentiation 
 
The pioneering studies conducted by Miller and Osoba (1967) have demonstrated the active 
role played by the thymus in the generation of peripheral T lymphocytes, and its previously 
assumed function as an endocrine gland was less and less considered. From the primary sites 
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of hemopoiesis (fetal yolk sac, liver, and then bone marrow), possibly under the control of 
some chemokines, T-cell precursors enter into the thymus through capillaries at the cortico-
medullary junction, then migrate to the subcapsular cortex (Fig. 1). An intense proliferation 
of T-cell blasts takes place in the outer cortex. The transmembrane molecule Notch-1 plays an 
important role in the induction of T-lineage restriction and commitment. Then, intimate 
contacts with TECs/TNCs promote the activity of the recombination-activating genes (RAG 1 
and RAG 2). RAG-catalyzed generation of T cell diversity occurs through the random 
recombination of gene segments encoding the variable parts of the T-cell antigen receptor 
(TCR) (Fugmann et al., 2000). TCR recombination and expression by thymocytes (pre-T 
cells) constitutes a pivotal event because, among the number of about 108 possible 
combinations, many of them are able to recognize self-antigens presented by the major 
histocompatibility complex (MHC) proteins expressed by TECs/TNCs, DCs and 
macrophages. The so-called thymic negative selection represents the massive deletion of T-
cell clones expressing self-reactive TCR and results either from programmed cell death or 
developmental arrest. Thymus censorship is responsible for the establishment of central T-
cell self-tolerance (Nossal, 1994). This fundamental process is very powerful since, from 100 
T-cell precursors, only 1-2 T cells will leave the thymus in a state of self-tolerance and 
competence against foreign antigens. 
 
The concomitant occurrence within the same organ of opposite events such as T- cell 
negative selection and T-cell life/diversity generation represents a prominent problem in 
modern biology. A number of models have been proposed to explain the paradox of thymus 
physiology. A first model attributed different functional roles to the cells of thymic stroma: 
TECs/TNCs would be mainly responsible for inducing T-cell proliferation and development, 
whereas thymic DCs and macrophages, as dedicated antigen-presenting cells (APCs), would 
mediate T-cell negative selection. Although DCs and macrophages are very efficient in 
inducing T-cell deletion, this model is no more valid since it is now demonstrated that 
TECs/TNCs are also able to present self-antigens and provoke T-cell negative selection. 
Medullary TECs in particular are highly competent in achieving self-tolerance. The most 
popular model is called the avidity model (Ashton-Rickardt et al., 1994): T cells bearing a 
TCR with a high affinity for self-antigen at high density will undergo clonal deletion, while 
those with a low-affinity TCR and/or in presence of low-density self-antigen survive and 
further develop. However, the affinity of a given TCR for its cognate antigen is rather low 
(with a KD around 10-7 M), and thus one may question the physiological meaning of lower 
affinities. The model of the dual role played by the repertoire of thymic neuroendocrine-
related genes recapitulates at the molecular level the paradox of thymus physiology. 
According to this model, thymic neuroendocrine-related precursors are the source of two 
distinct types of interactions with immature T cells. On the one hand these precursors deliver 
ligands that are not secreted but targeted to the outer surface of TECs/TNCs from where they 
can bind to neuroendocrine receptors expressed by immature T cells. A high affinity (KD 
ranging from 10-11 to 10-9 M) and a low specificity characterize this cryptocrine type of 
signaling. On the other hand the same precursors undergo antigen processing and are the 
source of neuroendocrine self-peptides presented by the thymic MHC machinery. A negative 
signal would result from the low-affinity  but highly specific binding of the complex 
MHC/neuroendocrine self-antigen to its cognate TCR. According to the theory of clonal 
deletion, the central T-cell self-tolerance of neuroendocrine principles results from the 
intrathymic presentation of neuroendocrine self-antigens (Fig. 2).  
 
In addition to deletion of self-reactive T-cell clones, the establishment of central thymic self-
tolerance also includes the generation of regulatory T cells (TREG) that are enriched in the 
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CD4+ CD25+ T cell subset (Shevach, 2000; Sakagushi, 2001). It remains to be determined 
how far the thymic self-antigen repertoire contributes to the generation of TREG lymphocytes.  
 
4.   The nature of neuroendocrine self (Table I) 
 
From the investigation of intrathymic expression of neuroendocrine-related self-peptide 
precursor genes, a series of properties were drawn to define the nature of neuroendocrine self. 
(1) Neuroendocrine self-antigens usually correspond to peptide sequences that have been 
highly conserved throughout the evolution of one given family. (2) A hierarchy characterizes 
their expression pattern. In the neurohypophysial family, oxytocin (OT) is the dominant 
peptide synthesized by TECs/TNCs from different species (Geenen et al., 1986). The binding 
of OT to OT receptor (OTR) expressed by pre-T cells induces a very rapid phosphorylation of 
focal adhesion related kinases. This event should play a major role in the promotion of 
immunological “synapses” between immature T lymphocytes and thymic APCs 
(TECs/TNCs, macrophages and DCs). With regard to tachykinins, neurokinin A (NKA)—but 
not substance P (SP)—is the peptide generated from the processing by TECs of the 
preprotachykinin A (PPT-A) gene product (Ericsson et al., 1990). All the genes of the insulin 
family are expressed according to a precise hierarchy and topography: IGF2 (TECs/TNCs) > 
IGF1 (thymic macrophages) >> INS (thymic DCs and/or medullary TECs) (Geenen and 
Lefèbvre, 1998; Derbinski et al., 2001). This hierarchical pattern is meaningful since the 
tolerogenic response primarily concerns the dominant epitopes of a protein family (Sercarz et 
al., 1993). In fetal thymic organ cultures, the blockade of thymic IGF-mediated signaling, at 
the level of IGF ligands (in particular IGF-2) or IGF receptors, severely interferes with early 
stages of T-cell differentiation and proliferation. On the contrary, the treatment of fetal 
thymic organ cultures with antibodies against (pro)insulin does not exert any significant 
effect on T-cell differentiation (Kecha et al., 2000). (3) Neuroendocrine precursors are not 
processed in a classic fashion, but they undergo antigenic processing for presentation by, or in 
association with, thymic MHC proteins. (4) Some differences exist in the processing between 
thymic APCs and dedicated peripheral APCs. At least for some neuroendocrine self-antigens 
(OT and neurotensin), those differences imply that their presentation by thymic APCs is not 
restricted by MHC alleles like presentation of foreign antigens by peripheral APCs (Vanneste 
et al., 1997; Geenen et al., 1999). 
 
During ontogeny of Balb/c mice, OT transcripts are detected on fetal day 13 (E13) both in 
thymus and brain, whereas vasopressin (VP) gene transcription starts on E14 in the brain and 
is clearly detected in the thymus only on E15. The earlier OT expression in the thymus 
supports the role of thymic OT in the induction of central T-cell tolerance of the 
neurohypophysial peptides before their appearance in the hypothalamic magnocellular 
neurons (Fig. 3). The expression of the neurohypophysial receptor genes (OTR, V1R, V2R and 
V3R) was investigated on murine thymic CD4- CD8- lymphoma cell lines, as well as on 
murine thymic T-cell subsets. OTR transcripts are detected in CD4-CD8-, CD4+ CD8+ and 
CD8+ cells, while a faint V3R expression is restricted to CD4+ CD8+ and CD8+ cells. V1R and 
V2R expression could not be detected on any T cell subset. In fetal thymic organ cultures, a 
specific OTR antagonist increases late T-cell apoptosis confirming the involvement of 
OT/OTR-signaling in T-cell proliferation/survival (Hansenne et al., in press). 
 
5.  The development of autoimmunity as a defect in thymic self-tolerance establishment 
 
In 1992, a defect in thymic T-cell education to recognize and to tolerate self-antigens was 
hypothesized to play a pivotal role in the development of hypothalamus-specific 
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autoimmunity (Geenen et al., 1992; Robert et al., 1992). As already hypothesized by Burnet 
(1973), the pathogenesis of autoimmune diseases could result from the appearance of 
“forbidden” self-reactive clones in the peripheral lymphocyte repertoire. Since the thymus is 
the primary site for induction of self-tolerance, thorough investigation of a defective thymic 
censorship should provide the scientific community with important keys to understand the 
mechanisms underlying the development of autoimmune responses. A number of 
abnormalities of thymic morphology and cytoarchitecture have been described for several 
autoimmune disorders. The expression of the transcription factor autoimmune regulator 
(AIRE) gene is maximal in murine medullary TECs, but it is absent in the thymus epithelium 
of diabetic NOD mice (Heino et al., 2000). Type 1 diabetes (juvenile or insulin-dependent 
diabetes) is a chronic devastating disease resulting from an autoimmune response specifically 
oriented against pancreatic islet ß cells, the only cells secreting insulin according to the 
endocrine model. In accordance with the above hypothesis, INS transcripts were measured at 
lower levels in the thymus of human fetuses with short class I VNTR (variable number of 
tandem repeats) alleles, a genetic trait of type 1 diabetes susceptibility (Vafiadis et al., 1997; 
Pugliese et al., 1997). The expression of insulin-related genes was also analyzed in thymus, 
liver and brain of a common animal model of type 1 diabetes, the bio-breeding (BB rat). A 
defect of Igf2 expression was evidenced in the thymus of more than 80% of diabetes-prone 
BB rats, in close accordance with the incidence of diabetes in this rat strain (Kecha-Kamoun 
et al., 2001). In these rats, this tissue-specific defect in Igf2 transcription could contribute 
both to lymphopenia (including a lack of antigen-specific TREG cells that control autoimmune 
diabetes), as well as to the absence of central self-tolerance of insulin family. As a 
consequence of the defective thymic censorship, self-reactive T cells bearing TCR oriented 
against dominant epitopes of insulin-related peptides continuously migrate from the thymus 
and enrich the peripheral pool with self-reactive T cells exhibiting a potential cytotoxic power 
against islet ß cells. Under certain environmental influences, a molecular bridge could be 
installed between the target autoantigenic epitopes leading to activation of the self-reactive T-
cell pool and subsequent ß-cell destruction (Fig. 4). Diabetes-prone NOD mice also display a 
defect in central tolerance (negative selection) of T lymphocytes (Kishimoto and Sprent, 
2001). The transcription of genes encoding tissue-specific antigens (including Ot, Igf2, Ins2, 
and Npy) is markedly down-regulated in the thymus epithelium of Aire-/- mice (Anderson et 
al., 2002). Moreover, Aire deficiency results in an almost complete thymic failure to delete 
CD4+ T cells with high affinity for a pancreas-specific antigen (Liston et al., 2003). Thus, 
more and more arguments provide strong evidence that a defect in thymic self-tolerance plays 
a pivotal role in the pathogenesis and development of organ-specific autoimmunity. The 
origin of systemic (non-organ specific) autoimmunity is still a matter of debate and could be 
elucidated through further investigations of the non-specific, innate immune system. 
 
6.  Pharmacological applications and conclusions 
 
The study of neuroendocrine gene expression and precursor processing in the thymus led to 
the identification of neuroendocrine self-peptides. With regard to insulin-related gene 
expression in the thymus, IGF-2—a prominent fetal growth factor—was identified as the 
dominant self-peptide precursor of the insulin family expressed in the thymus from different 
species, including man. This observation is in close accordance with the theory of self-
recognition which, according to F.M. Burnet, is not an inherited property but is gradually 
acquired in the course of fetal life. Although the tolerogenic properties of neuroendocrine 
self-peptides remain to be further documented, they are suspected from what is known about 
the immunological tolerance of classic hormones. The development of specific antibodies by 
active immunization (i.e., experimental breakdown of self-tolerance) revealed that OT is 
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more tolerated than VP, and that IGF-2 is also more tolerated than IGF-1, and much more 
than insulin. Some cases of diabetes insipidus result from an autoimmune process against VP-
producing hypothalamic neurons (infundibulohypothalamitis) (Scherbaum et al., 1985; Imura 
et al., 1993). Insulin is a primary autoantigen tackled by the autoimmune response observed 
in type 1 diabetes and this might result from its very low expression in the thymus. At the 
opposite, autoimmunity has never been observed against OT and IGF-2. The strong tolerance 
of these peptides, resulting from high expression of their genes in the thymus, may be 
considered as the consequence of evolutive pressure to protect fundamental processes such as 
species reproduction and individual ontogeny (Geenen et al., 1999). The putative pathogenic 
role of forbidden self-reactive T cells against IGF-2 deserves to be further analyzed through 
immunization of Igf2-/- mice.  
 
Thus although VP and insulin behaves as immunogenic auto-antigens of their respective 
families, OT and IGF-2 may be viewed as the tolerogenic self-peptide precursors of 
neurohypophysial and insulin families, respectively. Quite provocatively, perhaps is it now 
appropriate to establish a distinction between an auto-antigen and a self-antigen (Fig. 5). 
According to this distinction, auto-antigens can be considered as “altered” self-antigens. 
Though they are highly homologous, i.e., evolutionarily related, they are not identical and this 
biochemical difference theoretically drives opposite immune responses (i.e., immunogenic vs. 
tolerogenic responses). This proved to be correct in a recent preclinical study. A dominant 
epitope of insulin (Ins B9-23) and the homologous sequence of IGF-2 (IGF-2 B11-25) compete 
for binding to DQ8, a MHC class II allele conferring major susceptibility to type 1 diabetes. 
In young DQ8+ type 1 diabetic patients, Ins B9-23 presentation by DQ8 elicits a dominant IFN-
γ secretion by isolated peripheral blood mononuclear cells, whereas presentation of IGF-2 
B11-25 promotes a dominant regulatory IL-10 secretion. The powerful tolerogenic properties of 
thymic self-antigens should be soon exploited to cure and/or prevent severe autoimmune 
diseases (such as type 1 diabetes) which constitute the heavy tribute, mainly paid by mankind, 
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8. Legends to figures 
 
Fig. 1: Pathways of intrathymic T-cell differentiation.  
From fetal liver then bone marrow, T-cell progenitors enter the thymus by capillaries at the 
cortico-medullary junction and migrate to the subcaspsular outer cortex where they divide 
intensively (T-cell blasts). Interactions between randomly rearranged TCR chains on 
thymocytes and self-antigen/MHC complexes presented by thymic stromal cells drive the 
programme of T-cell differentiation in the thymus. From 100 thymocyte precursors that enter 
the thymus, only 1-2 self-tolerant CD4+ helper and CD8+ cytotoxic emigrate from the 
thymus to establish the peripheral T-cell repertoire. 
 
 
Fig. 2: The dual role in the thymus of neuroendocrine-related self-peptide genes.  
Neuroendocrine gene-encoded precursors are the source of two types of interactions with pre-
T cells. (1) They deliver ligands, which are not secreted but targeted to the outer surface of 
thymic plasma cell membranes. Those ligands bind to T-cell neuroendocrine receptors 
leading to activation of transductory pathways such as increase of inositol triphosphate (IP3) 
and phosphorylation of focal adhesion kinases (FAK). (2) The same precursors are processed 
into self-antigens presented by—or in association with—thymic MHC molecules. This 
presentation will lead to clonal deletion and/or developmental arrest T cells bearing a TCR 
oriented against neuroendocrine self-antigens and MHC complexes. 
 
 
Fig. 3: Ontogeny of OT, VP and OTR expression in thymus and brain of Balb/c mouse. 
OT transcription is already detectable on E13 in both murine thymus and brain, whereas VP 
transcripts are detected in the brain later (E14), and are detected in the thymus only on E15. 
Though not quantitative, the profile of OTR expression seems to decrease in the thymus and 
to increase in the brain during fetal development. 
 
 
Fig. 4: Role of the thymus in the development of the autoimmune response against islet 
insulin-secreting ß cells.  
Together with abnormalities of thymic cytoarchitecture, the thymus-specific defect of IGF2 
expression contributes both to lymphopenia (with a decreased number of TREG cells) and to 
the absence of central T-cell self-tolerance of the insulin family. The influence of the 
environmental factors could be exerted at the level of thymic T-cell differentiation, as well as 
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in the periphery through the establishment of a bridge between the ß-cell auto-antigen and 
forbidden self-reactive T cells. Coxsackievirus B4 (CVB4) infection is a major environmental 
factor implicated in the pathogenesis of type 1 diabetes. Three mechanisms are currently 
proposed to explain the CVB4 diabetogenic influence: (1) molecular mimicry between 
sequences of glutamic acid decarboxylase (GAD) and a structural CVB4 protein; (2) direct 
toxic action of CVB4 toward islet ß cells and bystander activation of autoreactive T cells; and 
(3) CVB4 infection of the thymic epithelium and interference with the establishment of 
central T-cell self-tolerance (Brilot et al., 2002).  
 
 
Fig. 5: Opposite immune responses driven by insulin as an auto-antigen vs. IGF-2 as a self-
antigen precursor. 
As evidenced by numerous authors, insulin (Ins) is a major ß-cell specific auto-antigen 
tackled by the diabetogenic autoimmune response. Ins is immunogenic and the sequence B9-23 
is a dominant epitope recognized by pathogenic CD4+ T cells. IGF-2 is the dominant member 
of the insulin family expressed in TECs of different species and this may explain why the 
immune tolerance of IGF-2 is so hard to break. Both Ins B9-23 and the homologous sequence 
IGF-2 B11-25 bind with the same affinity to DQ8, one HLA class II allele conferring major 
susceptibility to type 1 diabetes. DQ8 presentation of IGF-2 B11-25 to peripheral blood 
mononuclear cells of type 1 diabetic patients elicits a dominant IL-10 secretion as revealed by 
Elispot analyses. The regulatory/tolerogenic properties of IGF-2 (or IGF-2 B11-25) could be 
exploited in a vaccination strategy to reprogram immune self-tolerance of the insulin family. 
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The fundamental principle is based upon the close homology between peripheral hormones 
and related thymic self-peptide genes/precursors. Tolerogenic neuroendocrine self-peptide 
precursors are predominantly conserved throughout evolution of their family and are the 
dominant members of one family that are expressed in the thymus. 
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